Product Information
ACYCLOVIR 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0962 per EA under NDC 31722077705. Its NADAC has been published 648 times since May 7, 2014.
FDA first approved this application on Oct 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722077705
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACYCLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA203834FDA Approved
10/29/2013
TE Code
AB
On Market Since
11/29/2013
Pharmacological Classes
Price Statistics
The NADAC for ACYCLOVIR 400 MG TABLET has been published 648 times since May 7, 2014, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0962 per EA |
|---|---|
| All-time high | $0.1245 (Jan 13, 2021) |
| All-time low | $0.0689 (Nov 20, 2024) |
| 52-week high | $0.1007 |
| 52-week low | $0.0912 |
| Median price | $0.1005 |
| Average price | $0.0997 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 648 |
| Tracking since | May 7, 2014 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acyclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACYCLOVIR 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0962 per EA (NDC 31722077705), effective Sep 30, 2026.
How has the price of ACYCLOVIR 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACYCLOVIR 400 MG TABLET has declined 17.7%. It has been tracked across 648 weekly CMS publications since May 7, 2014.
What are the highest and lowest recorded NADAC prices for ACYCLOVIR 400 MG TABLET?
Since May 7, 2014, the NADAC for ACYCLOVIR 400 MG TABLET has ranged from a low of $0.0689 (Nov 20, 2024) to a high of $0.1245 (Jan 13, 2021), with a median of $0.1005 per EA.
Are there cheaper alternatives to ACYCLOVIR 400 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACYCLOVIR 400 MG TABLET, is $0.0779 per EA — about 19% below ACYCLOVIR 400 MG TABLET.
Who manufactures ACYCLOVIR 400 MG TABLET?
ACYCLOVIR 400 MG TABLET (NDC 31722077705) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.